secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACHIEVE LIFE SCIENCES, INC. (ACHV)
CIK:        0000949858
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0000950170-25-003873
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Achieve Life Sciences appoints Nancy Phelan and Kristen Slaoui to board; Himes resigns
--------------------------------------------------------------------------------

- Dr. Vaughn Himes resigned from board effective Jan 6, 2025; no disagreement; will continue consulting.
- Board appointed Nancy R. Phelan and Kristen B. Slaoui, Ph.D. as directors, effective Jan 6, 2025.
- Each new director receives $40,000 annual retainer for FY2025 and stock option for 47,250 shares (3-yr vest).
- Additionally, annual equity option for 31,500 shares vesting over one year, subject to continued service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/0000950170-25-003873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/949858/000095017025003873/achv-20250106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-003873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer